Valuation Trading Multiples & Precedent Transactions: Injectable Drug Delivery Manufacturers
Valuation benchmarks for Injectable Drug Delivery Manufacturers. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Injectable Drug Delivery Manufacturers Market Context & Valuation Drivers
Companies in this trading comparable group manufacture and supply parenteral drug packaging and delivery systems, spanning glass containment (vials, cartridges, prefillable syringes, ampoules) and injectable device platforms (autoinjectors, pens, targeted infusion systems), plus supporting inspection and assembly solutions. They are comparable given shared GMP manufacturing, regulatory validation cycles, embedded supply agreements with pharma/biotech, and revenue models tied to drug launches and lifecycle volumes, yielding similar margin structures and capital intensity.
Typical capabilities include precision glass forming for vials, ampoules, cartridges, and prefillable syringes; sterile RTU preparation, coating and siliconization; device design and contract manufacturing for autoinjectors, pen injectors, and wearable injectors; targeted infusion and catheter-based delivery platforms; automated assembly, packaging, and vision inspection systems; container integrity and leak testing; and technical services covering human factors, regulatory support, and process validation to scale programs from development to commercial supply.
Primary buyers include global pharmaceutical manufacturers, emerging biotech developers, and hospital-based interventional therapy centers. Demand is driven by injectable pipeline growth and lifecycle management. Key valuation benchmarks include revenue growth from new program wins, capacity utilization and throughput on installed lines, long-term supply agreement visibility and backlog, and mix-driven gross and EBITDA margins from higher-value RTU containers, devices, and platform-based recurring volumes.
2. Valuation Analysis: Public Trading Comps & Multiples for Injectable Drug Delivery Manufacturers companies
2.1 - Public Peer Groups & Median Valuation Multiples for Injectable Drug Delivery Manufacturers sector
Comparable group 1: Injectable Drug Delivery Manufacturers
Schott Pharma
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of drug containment solutions and delivery systems for injectable drugs, offering advanced glass-based products including prefillable syringes, cartridges, vials, and ampoules, specialized in supporting the pharmaceutical and biotech industries.
- Key Products:
- Prefillable Syringes: High-quality glass syringes for various injectable drugs
- Cartridges: Glass cartridges designed for use in drug delivery devices
- Vials: Durable glass vials for injectable pharmaceuticals
- Ampoules: Secure glass ampoules for liquid medications
- Drug Delivery Systems: Comprehensive solutions for efficient drug administration
Stevanato Group
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of integrated systems, processes, and services for the pharmaceutical and healthcare industries, specializing in glass primary packaging, drug delivery devices, and assembly and packaging equipment. Offers comprehensive solutions to ensure the integrity and safety of medications through advanced technologies and engineering excellence.
- Key Products:
- Precision Glass Forming: Advanced glass forming lines for pharmaceutical packaging
- Vision Inspection Systems: Equipment for inspecting drug containment solutions
- Drug Delivery Devices: Production of autoinjectors, pen injectors, and wearable injectors
- Assembly and Packaging: Solutions for efficient assembly and packaging of medical products
- Pre-Sterilized Containers: EZ-fill® technology for ready-to-use drug packaging solutions.